---
document_datetime: 2023-09-21 17:46:50
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aprovel-epar-all-authorised-presentations_en.pdf
document_name: aprovel-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 4.8546203
conversion_datetime: 2025-12-22 20:57:09.263734
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging              | Content   | Package size   |
|-----------------|-----------------|------------|-----------------------|---------------------------|------------------------|-----------|----------------|
| EU/1/97/046/001 | Aprovel         | 75 mg      | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 28             |
| EU/1/97/046/002 | Aprovel         | 75 mg      | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 56             |
| EU/1/97/046/003 | Aprovel         | 75 mg      | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 98             |
| EU/1/97/046/004 | Aprovel         | 150 mg     | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 28             |
| EU/1/97/046/005 | Aprovel         | 150 mg     | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 56             |
| EU/1/97/046/006 | Aprovel         | 150 mg     | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 98             |
| EU/1/97/046/007 | Aprovel         | 300 mg     | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 28             |
| EU/1/97/046/008 | Aprovel         | 300 mg     | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 56             |
| EU/1/97/046/009 | Aprovel         | 300 mg     | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 98             |
| EU/1/97/046/010 | Aprovel         | 75 mg      | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 14             |
| EU/1/97/046/011 | Aprovel         | 150 mg     | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 14             |
| EU/1/97/046/012 | Aprovel         | 300 mg     | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 14             |
| EU/1/97/046/013 | Aprovel         | 75 mg      | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 56 x 1         |
| EU/1/97/046/014 | Aprovel         | 150 mg     | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 56 x 1         |
| EU/1/97/046/015 | Aprovel         | 300 mg     | Tablet                | Oral use                  | Blister (PVC/PVDC/alu) |           | 56 x 1         |
| EU/1/97/046/016 | Aprovel         | 75 mg      | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 14             |

<div style=\"page-break-after: always\"></div>

| EU Number       | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging              | Content   | Package size   |
|-----------------|-----------------|------------|-----------------------|---------------------------|------------------------|-----------|----------------|
| EU/1/97/046/017 | Aprovel         | 75 mg      | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 28             |
| EU/1/97/046/018 | Aprovel         | 75 mg      | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 56             |
| EU/1/97/046/019 | Aprovel         | 75 mg      | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 56 x 1         |
| EU/1/97/046/020 | Aprovel         | 75 mg      | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 98             |
| EU/1/97/046/021 | Aprovel         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 14             |
| EU/1/97/046/022 | Aprovel         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 28             |
| EU/1/97/046/023 | Aprovel         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 56             |
| EU/1/97/046/024 | Aprovel         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 56 x 1         |
| EU/1/97/046/025 | Aprovel         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 98             |
| EU/1/97/046/026 | Aprovel         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 14             |
| EU/1/97/046/027 | Aprovel         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 28             |
| EU/1/97/046/028 | Aprovel         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 56             |
| EU/1/97/046/029 | Aprovel         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 56 x 1         |
| EU/1/97/046/030 | Aprovel         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 98             |
| EU/1/97/046/031 | Aprovel         | 75 mg      | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 84             |
| EU/1/97/046/032 | Aprovel         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           | 84             |

<div style=\"page-break-after: always\"></div>

| EU Number       | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging              | Content   |   Package size |
|-----------------|-----------------|------------|-----------------------|---------------------------|------------------------|-----------|----------------|
| EU/1/97/046/033 | Aprovel         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           |             84 |
| EU/1/97/046/034 | Aprovel         | 75 mg      | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           |             30 |
| EU/1/97/046/035 | Aprovel         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           |             30 |
| EU/1/97/046/036 | Aprovel         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           |             30 |
| EU/1/97/046/037 | Aprovel         | 75 mg      | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           |             90 |
| EU/1/97/046/038 | Aprovel         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           |             90 |
| EU/1/97/046/039 | Aprovel         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/alu) |           |             90 |